Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept 50 mg Once Weekly in Plaque Psoriasis
NCT00333034Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jun 2006
- Modality
- Fc-Fusion Proteins
- Countries
- 10
01
Overview
A Phase 3 trial of etanercept in plaque psoriasis, sponsored by Pfizer. Started Jun 2006; status: completed.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00333034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00333034.